Korean J Intern Med.
2017 Jan;32(1):67-68. 10.3904/kjim.2016.419.
The role of early molecular predictor in transplant-eligible chronic myelogenous leukemia
- Affiliations
-
- 1Division of Hematology and Oncology, Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea. kshmoon@dau.ac.kr
- KMID: 2365979
- DOI: http://doi.org/10.3904/kjim.2016.419
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- BCR-ABLâ‚ transcripts (MR(4.5)) at post-transplant 3 months as an early predictor for long-term outcomes in chronic myeloid leukemia
- Development of peripheral T-cell lymphoma in the course of chronic myelogenous leukemia
- Clinical Experience of Leukemia with Extradural Chloroma during Treatment of Lower Back Pain
- A Case of Juvenile Chronic Myelogenous Leukemia Presented as Recurrent Erythema Nodosum-Like Lesions
- Erythema Nodosum Associated with Chronic Myelogenous Leukemia
